Eloxx Pharmaceuticals, Inc.
ELOXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $89.07M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.02$23.40
- Volume (live)
- -
- Avg. volume (3M)
- 24.16K
Eloxx Pharmaceuticals (ELOX) Stock Price & Financial Analysis
Eloxx Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $12.64 - $13.56 |
|---|---|
| 52-Week High | $23.40 |
| 52-Week Low | $0.02 |
| Open | $13.21 |
| Volume (last close) | 10.35K |
| Average Volume (3M) | 24.16K |
| 50-Day MA | $16.19 |
|---|
| Market Cap | 89.07M |
|---|---|
| Shares Outstanding | 6.79M |
| Price to Book (P/B) | 1.92 |
| EV/EBITDA | -2.46 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Eloxx Pharmaceuticals at a Glance
As of the Oct 22, 2026 close, Eloxx Pharmaceuticals (ELOX) has a market capitalization of $89.07M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $61.96M in cash and securities against $0.00 of debt, a net cash position of $61.96M.
Eloxx Pharmaceuticals does not currently pay a dividend.
At $13.12 (the Oct 22, 2026 close) it sits within its 52-week range of $0.02 to $23.40.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $38.25, 191.5% above the Oct 22, 2026 close.
Frequently Asked Questions About Eloxx Pharmaceuticals
What is the current stock price for ELOX?
As of the Oct 22, 2026 close, ELOX stock trades at $13.12. The 52-week range is $0.02–$23.40, with a day range of $12.64–$13.56.
What is the P/E ratio for ELOX?
The P/E ratio (Price-to-Earnings) for ELOX is shown in the Key Statistics section. This valuation metric helps compare Eloxx Pharmaceuticals, Inc. to industry peers.
Does ELOX pay dividends?
Eloxx Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ELOX?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for ELOX is Buy. The average 12-month price target is $38.25, a 191.5% upside from the Oct 22, 2026 close of $13.12.
What is the market cap of ELOX?
As of the Oct 22, 2026 close, Eloxx Pharmaceuticals's market capitalization is $89.1M, classifying it as a micro-cap company. Eloxx Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.